BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Orchid BioSciences, Inc. (ORCH) To Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference


10/19/2005 5:12:48 PM

PRINCETON, N.J., Feb. 22 /PRNewswire-FirstCall/ -- Orchid BioSciences, Inc. , a leading provider of identity DNA testing services, today announced that Paul J. Kelly, M.D., chief executive officer of Orchid, is scheduled to present at the BIO CEO & Investor Conference in New York City on Wednesday, February 23, 2005 at 3:00 p.m. ET. Dr. Kelly will provide a brief corporate overview and discuss the company's recent progress.

A live and archived webcast of Dr. Kelly's presentation can be accessed via the Investor Relations section of Orchid's website at http://www.orchid.com/. The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the webcast at http://www.fulldisclosure.com/, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors can access the webcast via Thomson's password-protected event management site, StreetEvents (http://www.streetevents.com/). The archived webcast will be available starting approximately one hour after the presentation and will be archived for 90 days.

About Orchid BioSciences

Orchid BioSciences is a leading provider of identity genetics services for the forensic and paternity DNA testing markets and for public health DNA testing for food safety. Orchid's strong market positions in these segments leverage the company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the world-renowned Cellmark and GeneScreen brands that have been associated with exceptional quality, reliability, innovation and customer service for nearly two decades. More information on Orchid can be found at http://www.orchid.com/.

Orchid BioSciences, Inc.

CONTACT: Tracy J. Henrikson, Executive Director, CorporateCommunications of Orchid BioSciences, +1-609-750-2221



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES